Detalles de la búsqueda
1.
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases.
J Intern Med
; 293(5): 648-655, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36843323
2.
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
JAMA
; 326(23): 2375-2384, 2021 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34932077
3.
A man in his fifties with abdominal pain, itching and weight loss. / En mann i 50-årene med magesmerter, kløe og vekttap.
Tidsskr Nor Laegeforen
; 140(3)2020 02 25.
Artículo
en Inglés, Nor
| MEDLINE | ID: mdl-32105028
4.
Correction: A man in his fifties with abdominal pain, itching and weight loss. / Rettelse: En mann i 50-årene med magesmerter, kløe og vekttap.
Tidsskr Nor Laegeforen
; 140(4)2020 03 17.
Artículo
en Nor
| MEDLINE | ID: mdl-32192268
5.
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials.
Lancet Rheumatol
; 6(4): e226-e236, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38402891
6.
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy.
RMD Open
; 8(2)2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36328399
Resultados
1 -
6
de 6
1
Próxima >
>>